News

Astellas is seeking approval to use Tarceva as the first-line therapy to treat patients with EGFR activating mutation-positive locally advanced or metastatic non-small cell lung cancer (NSCLC). The

Galapagos earns a milestone payment of EUR4m from Janssen for achieving the milestone of identifying a second pre-clinical candidate. According to the deal signed between the two companies

Company expects to complete the study within six to eight months and file for FDA clearance of APPY1 in the fourth quarter of 2013. Venaxis president and CEO

Company intends to begin the construction of the new facility shortly to expand the monoclonal antibody manufacturing capacity. Amgen operations executive vice president Madhu Balachandran said the planning

The solution, VisionTracker, which features an intuitive graphical interface, comes pre-loaded with the company’s Cryo and 2D barcoded Storage Tubes and Boxes, as well as freezers, allowing quick

NanoSmart Pharmaceuticals president Dr. James Smith said the collaboration will facilitate access to UCLA’s high level of research, development and clinical resources. "Their expertise in the development of

The drug development program, funded and carried out through Spitfire Pharma, will leverage EuMederis’ EuPort technology for optimization of the pharmaceutical properties of peptide drugs. Velocity Pharmaceutical Development

Under the collaboration, Genoa will combine its expertise in aerosol drug delivery with McMaster’s expertise in exploring mechanisms of pulmonary fibrosis and managing patients with IPF. McMaster University

New packaging system provides information regarding appropriate quantity for the treatment of chronic wounds and contains an applicator for easy usage. The transparent blister pack allows the physician